TSHA DCF Valuation - Taysha Gene Therapies Inc

Watchlist Manager

Watchlist

Price: 4.32 USD -5.68%

Market Cap: $1.2B

	Taysha Gene Therapies Inc NASDAQ:TSHA	US
	MSL Solutions Ltd ASX:MSL	AU
	Allovir Inc NASDAQ:ALVR	US
	Carlisle Companies Inc NYSE:CSL	US
S	Sundaram Clayton Ltd NSE:SUNCLAYLTD	IN
	CIMIC Group Ltd ASX:CIM	AU
	Ecora Resources PLC LSE:ECOR	UK
	Anglo Australian Resources NL ASX:AAR	AU
	Health and Happiness (H&H) International Holdings Ltd HKEX:1112	HK
	AMETEK Inc NYSE:AME	US
V	Vox Royalty Corp NASDAQ:VOXR	CA
	China Securities Co Ltd SSE:601066	CN
B	Bohai Leasing Co Ltd SZSE:000415	CN
	Marinus Pharmaceuticals Inc NASDAQ:MRNS	US
C	Creativeforge Games SA WSE:CFG	PL

TSHA's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.